BPA administration has been associated with modifications of ovarian steroidogenic enzymes including 17β hydroxylase, cholesterol side chain cleavage enzyme and steroidogenic acute regulatory protein, some of which are also implicated in PCOS hyperandrogenism [37]. This evidence concerns the gene STAR and polycystic ovary syndrome.